BBY
36
-4
C
60
2
ABBV
39
8
HAL
60
2
AEP
53
2
BWA
46
2
AMG
52
2
DOW
34
4
MCO
75
2
INTU
54
3
SJM
21
2
JNJ
44
3
AFL
49
3
AXP
69
3
EFX
36
4
KR
38
4
GILD
49
2
ADP
66
2
NTAP
66
2
IFF
56
3
BBY
36
-4
C
60
2
ABBV
39
8
HAL
60
2
AEP
53
2
BWA
46
2
AMG
52
2
DOW
34
4
MCO
75
2
INTU
54
3
SJM
21
2
JNJ
44
3
AFL
49
3
AXP
69
3
EFX
36
4
KR
38
4
GILD
49
2
ADP
66
2
NTAP
66
2
IFF
56
3
Financhill
Back

Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39

REGN
Regeneron Pharmaceuticals

Last Price:
737.85
Seasonality Move:
14.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Regeneron Pharmaceuticals Price Quote

$737.85
-6.65 (-0.89%)
(Updated: November 22, 2024 at 5:55 PM ET)

Regeneron Pharmaceuticals Key Stats

Sell
39
Regeneron Pharmaceuticals (REGN) is a Sell
Day range:
$737.63 - $751.40
52-week range:
$735.95 - $1,211.20
Dividend yield:
0%
P/E ratio:
21.41
P/S ratio:
6.19
P/B ratio:
2.79%
Volume:
971.4K
Avg. volume:
820.3K
1-year change:
-6.8%
Market cap:
$81.8B
Revenue:
$13.1B
EPS:
$40.41

How Much Does Regeneron Pharmaceuticals Make?

Is Regeneron Pharmaceuticals Growing As A Company?

Regeneron Pharmaceuticals Stock Price Performance

What Is Regeneron Pharmaceuticals 52-Week High & Low?

Regeneron Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Regeneron Pharmaceuticals?

Is Regeneron Pharmaceuticals Cash Flow Positive?

  • What Is REGN Cash Flow From Operations?
    Cash flow from operations (TTM) is $4.2B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.5B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.9B

Regeneron Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    REGN return on invested capital is 16.02%
  • What Is Regeneron Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 13.44%
  • What Is REGN Return On Equity?
    ROE is a measure of profitability and is 17.19%

Regeneron Pharmaceuticals Earnings Date & Stock Price

Regeneron Pharmaceuticals Competitors

Regeneron Pharmaceuticals Dividend Yield

Regeneron Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 29.81% 6.54%
Revenue: 10.65% 1.47%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 1,078.11
Upside from Last Price: 44.81%

Major Shareholders

  • How many REGN shares are owned by institutional investors?
    173.4M REGN shares are owned by institutional investors
  • How many REGN shares are owned by insiders?
    2.1M REGN shares are owned by insiders